Nancy F. Olivieri

13.9k total citations · 3 hit papers
169 papers, 9.4k citations indexed

About

Nancy F. Olivieri is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nancy F. Olivieri has authored 169 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Genetics, 110 papers in Hematology and 45 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nancy F. Olivieri's work include Hemoglobinopathies and Related Disorders (140 papers), Iron Metabolism and Disorders (97 papers) and Blood groups and transfusion (30 papers). Nancy F. Olivieri is often cited by papers focused on Hemoglobinopathies and Related Disorders (140 papers), Iron Metabolism and Disorders (97 papers) and Blood groups and transfusion (30 papers). Nancy F. Olivieri collaborates with scholars based in Canada, United States and United Kingdom. Nancy F. Olivieri's co-authors include Gary M. Brittenham, Elliott Vichinsky, Gideon Koren, David G. Nathan, Douglas M. Templeton, Peter P. Liu, John B. Porter, Alan R. Cohen, Patricia J. Giardina and Melvin H. Freedman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Nancy F. Olivieri

165 papers receiving 8.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron-Chelating Therapy and the Treatment of Thalassemia

1997 883 citations Nancy F. Olivieri, Gary M. Brittenham Blood profile →
Survival in Medically Treated Patients with Homozygous β-Thalassemia

1994 702 citations Nancy F. Olivieri, Peter P. Liu et al. New England Journal of Medicine profile →
The β-Thalassemias

1999 559 citations Nancy F. Olivieri New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy F. Olivieri Canada	51	7.3k	6.4k	2.1k	1.1k	1.0k	169	9.4k
Antonio Piga Italy	44	6.7k 0.9×	6.1k 0.9×	1.6k 0.8×	1.2k 1.1×	626 0.6×	195	8.8k
John B. Porter United Kingdom	64	9.6k 1.3×	9.1k 1.4×	2.0k 1.0×	2.1k 1.8×	1.5k 1.5×	468	14.2k
Alì Taher Lebanon	58	9.9k 1.4×	9.7k 1.5×	1.9k 0.9×	867 0.8×	1.1k 1.0×	533	14.6k
Victor R. Gordeuk United States	57	6.6k 0.9×	6.5k 1.0×	1.1k 0.5×	2.0k 1.7×	1.8k 1.8×	401	11.8k
Eliezer A. Rachmilewitz Israel	44	5.1k 0.7×	4.6k 0.7×	892 0.4×	828 0.7×	1.4k 1.4×	169	7.7k
Ellis J. Neufeld United States	58	2.8k 0.4×	4.2k 0.7×	1.2k 0.6×	674 0.6×	2.1k 2.1×	241	10.4k
Samir K. Ballas United States	49	8.6k 1.2×	6.8k 1.1×	2.5k 1.2×	208 0.2×	1.0k 1.0×	292	11.0k
Iain C. Macdougall United Kingdom	49	3.1k 0.4×	6.6k 1.0×	633 0.3×	704 0.6×	1.7k 1.7×	187	12.0k
Maria Domenica Cappellini Italy	70	14.0k 1.9×	12.5k 1.9×	4.0k 1.9×	1.6k 1.4×	2.8k 2.8×	565	20.8k
Lawrie W. Powell Australia	63	6.3k 0.9×	8.6k 1.3×	463 0.2×	5.8k 5.1×	1.4k 1.4×	295	14.2k

Countries citing papers authored by Nancy F. Olivieri

Since Specialization

Citations

This map shows the geographic impact of Nancy F. Olivieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy F. Olivieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy F. Olivieri more than expected).

Fields of papers citing papers by Nancy F. Olivieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy F. Olivieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy F. Olivieri. The network helps show where Nancy F. Olivieri may publish in the future.

Co-authorship network of co-authors of Nancy F. Olivieri

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy F. Olivieri. A scholar is included among the top collaborators of Nancy F. Olivieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy F. Olivieri. Nancy F. Olivieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morris, Claudia R., Hae-Young Kim, John C. Wood, et al.. (2012). Cardiopulmonary and Laboratory Profiling of Patients with Thalassemia At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network.. Blood. 120(21). 2122–2122. 1 indexed citations

Allen, Angela, Anuja Premawardhena, Tim Peto, et al.. (2011). Adaptation to anemia in hemoglobin E-β thalassemia (Blood (2010) 116, 24 (5368-5370)). Blood. 118. 6994–6995. 6 indexed citations

Kwiatkowski, Janet L., Alexis A. Thompson, Charles T. Quinn, et al.. (2009). Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort.. Blood. 114(22). 4056–4056. 5 indexed citations

Adams, Robert J., Donald Brambilla, Virgil McKie, et al.. (2000). Stroke prevention in sickle cell disease (stop): Final results. Blood. 96. 6 indexed citations

Carção, Manuel, L. Chang, Annette Poon, et al.. (1999). Compound Heterozygosity for Hb S and Hb G-Copenhagen. Hemoglobin. 23(4). 379–381.

Adamkiewicz, Thomas V., et al.. (1998). Infection Due to Yersinia enterocolitica in a Series of Patients with α-Thalassemia: Incidence and Predisposing Factors. Clinical Infectious Diseases. 27(6). 1362–1366. 49 indexed citations

Saxon, Ben, David C. Rees, & Nancy F. Olivieri. (1998). Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in β thalassaemia. British Journal of Haematology. 101(3). 416–419. 65 indexed citations

Olivieri, Nancy F. & Gary M. Brittenham. (1998). Long‐Term Trials of Deferiprone in Cooley's Anemia^a. Annals of the New York Academy of Sciences. 850(1). 217–222. 10 indexed citations

Clawson, Gary A., et al.. (1997). Expression of SCL Is Normal in Transfusion-Dependent Diamond-Blackfan Anemia But Other bHLH Proteins Are Deficient. Blood. 90(5). 2068–2074. 20 indexed citations

10.

Olivieri, Nancy F., Peter P. Liu, Graham D. Sher, et al.. (1994). Combined Liver and Heart Transplantation for End-Stage Iron-Induced Organ Failure in an Adult with Homozygous Beta-Thalassemia. New England Journal of Medicine. 330(16). 1125–1127. 52 indexed citations

11.

Waye, John S., et al.. (1994). Hb E/Hb Lepore_Hollandia in a family from Bangladesh. American Journal of Hematology. 47(4). 262–265. 16 indexed citations

12.

Waye, John S., Barry Eng, Nancy F. Olivieri, & David H.K. Chui. (1994). Identification of a novel β⁰ ‐ thalassaemia mutation in a greek family and subsequent prenatal diagnosis. Prenatal Diagnosis. 14(10). 929–932. 6 indexed citations

13.

Olivieri, Nancy F., Doreen Matsui, Laurence M. Blendis, et al.. (1993). Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients.. PubMed. 12 Suppl 1. 9–11. 5 indexed citations

14.

Matsui, Doreen, et al.. (1992). Clinical use of the Medication Event Monitoring System: A new window into pediatric compliance. Clinical Pharmacology & Therapeutics. 52(1). 102–103. 17 indexed citations

15.

Olivieri, Nancy F., Gideon Koren, Jonathan Harris, et al.. (1992). Growth Failure and Bony Changes Induced by Deferoxamine. Journal of Pediatric Hematology/Oncology. 14(1). 48–56. 104 indexed citations

16.

Klein, Julia, et al.. (1991). A High-Performance Liquid Chromatographic Method for the Measurement of the Iron Chelator 1,2-Dimethyl-3-hydroxypyridin-4-one in Human Plasma. Therapeutic Drug Monitoring. 13(1). 51–54. 11 indexed citations

17.

Ward, Michael, et al.. (1991). Detection of β-thalassemia using an artifical-restriction fragment length polymorphism generated by the polymerase chain reaction. Nucleic Acids Research. 19(4). 959–959. 7 indexed citations

18.

Miller, Barbara A., et al.. (1990). Interferon-γ Modulates Fetal Hemoglobin Synthesis in Sickle Cell Anemia and Thalassemia. Journal of Interferon Research. 10(4). 357–366. 4 indexed citations

19.

Bentur, Yedidia, et al.. (1990). Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity. Clinical Pharmacology & Therapeutics. 47(4). 478–482. 29 indexed citations

20.

Freedman, M. H., Gideon Koren, Yedidia Bentur, et al.. (1990). Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients. The Lancet. 336(8726). 1275–1279. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact